Glenn Sobotka's most recent trade in Agilon Health Inc was a trade of 334 Common Stock done at an average price of $23.1 . Disclosure was reported to the exchange on April 14, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Agilon Health Inc | Glenn Sobotka | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.07 per share. | 14 Apr 2022 | 334 | 5,365 | - | 23.1 | 7,705 | Common Stock |
Agilon Health Inc | Glenn Sobotka | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.57 per share. | 04 Nov 2021 | 150,000 | 153,260 | - | 7.6 | 1,135,500 | Common Stock |
Agilon Health Inc | Glenn Sobotka | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 150,000 | 0 | - | - | Options (Rights to Buy) | |
Agilon Health Inc | Glenn Sobotka | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 25.19 per share. | 04 Nov 2021 | 150,000 | 3,260 | - | 25.2 | 3,778,500 | Common Stock |
Agilon Health Inc | Glenn Sobotka | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2021 | 11,102 | 11,102 | - | - | Options (Rights to Buy) | |
Agilon Health Inc | Glenn Sobotka | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2021 | 3,260 | 3,260 | - | 0 | Common Stock |